The Prognostic Value of Serum Biomarkers for Survival of Children with Osteosarcoma of the Extremities.
Stefano BasoliMonica CosentinoMatteo TraversariMarco ManfriniShinji TsukamotoAndreas F MavrogenisBarbara BordiniDavide Maria DonatiConstantino ErraniPublished in: Current oncology (Toronto, Ont.) (2023)
AP and ESR can identify osteosarcoma-diagnosed children with a greater risk of death and local recurrence, respectively.